Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
European Journal of Obstetrics & Gynecology and Reproductive Biology（2020）
摘要
These results support a role for Astodrimer 1 % Gel as an effective, safe and well-tolerated treatment for women with bacterial vaginosis.
更多查看译文
关键词
Astodrimer gel,Bacterial vaginosis,Biofilm,Dendrimer,SPL7013,Treatment,VivaGel®
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要